BGPT: Paper Review: Tom70-based transcriptional regulation of mitochondrial biogenesis and aging

Explore by Goal

Quick Answer Copied

Core claim

The paper argues that Tom70 is more than a mitochondrial import receptor: it controls nuclear transcription of mitochondrial proteins to coordinate mitochondrial biogenesis with protein import/proteostasis, and that Tom70 decline with age contributes to mitochondrial dysfunction; TOM70 overexpression extends yeast replicative lifespan.

Evidence includes: Tom70 overexpression increasing mitochondrial protein abundance and mtDNA; mtDNA dependence for the transcriptional program; Tom70 required for import-defect–triggered repression to prevent cytosolic aggregation; and promoter engineering that restores Tom70/membrane potential during yeast aging.

Long Answer

Paper Review (Evidence-based & Skeptical)

"Tom70-based transcriptional regulation of mitochondrial biogenesis and aging" (eLife, 2022-03-02; DOI: 10.7554/eLife.75658)

1) What the authors set out to prove

The paper’s central problem statement is coordination: mitochondrial biogenesis has (at least) transcriptional activation of nuclear-encoded mitochondrial proteins, and mitochondrial import of nascent proteins; nascent mitochondrial proteins are aggregation-prone and can stress cytosolic proteostasis if import is outpaced. The authors hypothesize that Tom70 links these steps, so mitochondrial biogenesis activation does not create a cytosolic aggregation problem.

2) Evidence map (mechanism-to-phenotype pipeline)

Tom70 OE → mitochondrial protein abundance increases (tom70 OE outperforms Hap4 OE on a sampled mitochondrial-protein panel; Tom71 OE fails in the same setup).
Tom70 OE → transcriptional activation of nuclear-encoded mitochondrial genes; removing Tom70 from mitochondria via TEV reduces transcripts for many mitochondrial genes; Tom70 must be on the outer membrane (cytosolic domain alone is insufficient).
Downstream TFs are not just canonical retrograde RTG1/3; Rtg1/3 nuclear/cytosolic ratios are unchanged in Tom70 OE, and deleting Rtg3 does not block the Tom70-driven biogenesis program. The authors use promoter/TF in-silico predictions to identify TFs including Fkh1/2, with partial dependency.
Tom70 OE increases mtDNA, and mtDNA is required for the Tom70 transcriptional activation of many nuclear-encoded mitochondrial proteins; Mip1 abundance increases with Tom70 OE (and Mip1 OE increases mtDNA).
Import defect response requires Tom70: in tim23 ts import-defect conditions, Tom70 loss leads to cytosolic aggregation (Hsp104-GFP aggregates) rather than repression of biogenesis; conversely, Tom70 OE can overwrite the repressive state under import impairment and causes aggregation, whereas HAP4 OE does not.
Aging: Tom70 abundance declines; restoring Tom70 rescues mitochondrial dysfunction and delays replicative aging. The authors use promoter replacement and show Tom70 OE preserves membrane potential and mitochondrial protein abundance during aging; deleting Tom70 accelerates age-associated loss of mitochondrial potential/biogenesis and mtDNA loss.

3) Visualizations from explicit numbers stated in the paper text

Because the provided input text does not include the full figure-level numeric data needed to reconstruct continuous curves, the plots below use only explicitly stated counts/sample sizes and discrete experimental design contrasts.

Sample size backbone (explicitly stated)

Old-cell purification and mtDNA imaging sample sizes mentioned in the provided text.

Note: This chart is intentionally conservative—bars correspond only to the sample sizes that appear verbatim in the provided full-text excerpt.

Replicative lifespan assay cell counts (explicit)

pGAL-TOM70 vs pGAL-TOM70tm-mCH (as stated).

4) Mechanistic interpretation—what’s strong vs what’s inferential

4.1 Stronger support (more direct causality)

Localization requirement: Tom70’s cytosolic overexpression (without mitochondrial localization) does not activate the transcriptional program, implying the effect is not a generic cytosolic transcription-stimulation artifact.
Import-defect logic: in tim23 ts conditions, the absence of Tom70 prevents repression of mitochondrial biogenesis and correlates with cytosolic aggregation (Hsp104-GFP aggregates). This is mechanistically aligned with the idea that Tom70 couples import capacity to biogenesis output.
mtDNA dependence: in ρ0 cells (mtDNA-less petite cells), Tom70 OE fails to activate the transcription of nuclear-encoded mitochondrial proteins (as stated). That is an unusually direct dependency claim rather than a correlation-only story.

4.2 Key uncertainties / inferential steps

Direct molecular link is not fully pinned down: The paper uses in-silico promoter/TF motif prediction to identify downstream TFs and tests several TF perturbations (including Rtg1/3 independence and partial dependence on Fkh1/2). However, the provided text does not show direct Tom70–TF binding or direct occupancy assays (e.g., whether Tom70 affects TF recruitment at specific promoters). Therefore, the TF network is supported by perturbation logic but still inferential.
Overexpression risks: Many claims are made using TOM70 OE via inducible promoters (GAL, Z3EV). Overexpression can push systems into non-physiological regimes (stoichiometry, import overload, transcriptional saturation). The authors do test cytosolic proteostasis stress under import impairment (Tom70 OE during tim23 ts), which helps—but it does not fully eliminate non-physiological overexpression concerns.
Species extrapolation: Conservation is claimed for Drosophila (TOM70 OE in muscles increases mitochondrial biogenesis and is tested via RT-qPCR). But Drosophila and yeast mitochrondrial regulation differs; the paper text provided does not include a deep mammalian mechanistic validation.

5) Aging claim—what would falsify it?

The proposed aging mechanism is that Tom70 abundance decreases with age due to changes in transcription and degradation, and that this decline contributes to mitochondrial dysfunction and reduced replicative lifespan. The provided text includes promoter replacement rescue (Tom70 restored → membrane potential and mitochondrial proteins improved; mtDNA defects and RLS changes tracked with Tom70 manipulations).

Disproof targets (directly testable)

If Tom70 promoter replacement does not preserve membrane potential/mitochondrial proteins in aged cells, the causal aging contribution would weaken.
If Tom70 KO/knockout fails to accelerate mitochondrial dysfunction or mtDNA loss with age, the claim that Tom70 decline is contributory (rather than coincidental) would weaken.
If in ρ0 cells Tom70 OE still robustly activates nuclear-encoded mitochondrial gene transcription, the mtDNA dependency would be falsified.

6) Internal consistency checks (quick skepticism)

Tom70 OE increases biogenesis—but also must maintain cytosolic proteostasis by increasing import capacity; the paper supports this with an import-defect model where Tom70 becomes required to execute repression and prevent aggregation.
mtDNA dependency adds specificity that is not automatically predicted by “more Tom70 equals more transcription.” The requirement for mtDNA implies an indirect or mtDNA-driven signaling loop is involved.

7) Bespoke BGPT follow-up actions (buttons)

Author reviews (open BGPT deep dives)

Feedback:

Updated: April 28, 2026